| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/02/2000 | CN1261880A Inhibitors of farnesyl protein transferase |
| 08/02/2000 | CN1261877A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors |
| 08/02/2000 | CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 08/02/2000 | CN1261803A Antioxidant enhancement of therapy for hyperproliferative conditions |
| 08/02/2000 | CN1261802A Leptin as an inhibitor of tumor cell proliferation |
| 08/02/2000 | CN1261800A Method of treatment of lever tumours and pharmaceutical compositions for use therein |
| 08/02/2000 | CN1261602A Alcohol derivative of Triperygium wilfordii lactone and its application |
| 08/02/2000 | CN1261534A Medicinal composition containing naphthyl compound |
| 08/02/2000 | CN1055123C Protein structure of plant torin gelonin |
| 08/02/2000 | CN1055093C Glucosamine disaccharides, its preparation and use, and pharmaceutical composition comprising same |
| 08/02/2000 | CN1055089C Intermediate of protein kinase C inhibitor and its preparation |
| 08/02/2000 | CN1055087C Method and apparatus for extracting taxol from source material |
| 08/02/2000 | CN1055020C Method for preparing anti-tumour Chinese medicinal liquor |
| 08/02/2000 | CN1055002C External use cream for treatment of breast cancer |
| 08/02/2000 | CN1054996C Anti-cancer capsule |
| 08/01/2000 | US6096909 Taxoid anti-tumor agents and pharmaceutical compositions thereof |
| 08/01/2000 | US6096904 Discodermolides |
| 08/01/2000 | US6096902 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 08/01/2000 | US6096787 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 08/01/2000 | US6096778 α-ketoamide multicatalytic protease inhibitors |
| 08/01/2000 | US6096777 Method for inhibiting the expression of Fas |
| 08/01/2000 | US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding |
| 08/01/2000 | US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 08/01/2000 | US6096753 Substituted pyrimidinone and pyridone compounds and methods of use |
| 08/01/2000 | US6096750 Furopyrimidines and methods of making and using the same derivatives |
| 08/01/2000 | US6096749 Pyrrolopyrimidine derivatives having pharmacological activity |
| 08/01/2000 | US6096734 Photosensitizers for sensitizing cells |
| 08/01/2000 | US6096732 Steroid esters, process for their production and their pharmaceutical use |
| 08/01/2000 | US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors |
| 08/01/2000 | US6096720 Liposomal oligonucleotide compositions |
| 08/01/2000 | US6096713 Administering to patient a linear or cyclized derivative of glutamic acid-tryptophan dipeptide or a low molecular weight oligo- or polypeptide based upon the dipeptide unit |
| 08/01/2000 | US6096526 Amino acid sequences; for diagnosis, treatment and prevention of cancer and developmental disorders; anticarcinogenic agents; antagonists; agonists; antibodies; hybridization probes; recombinant production of enzyme |
| 08/01/2000 | US6096359 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 08/01/2000 | US6096318 Antigenically modified HCG polypeptides |
| 08/01/2000 | US6096313 Immunology using peptides of amino acid sequences |
| 08/01/2000 | US6096308 Human protein kinase and kinase inhibitors |
| 08/01/2000 | US6096300 Suppression of myeloproliferation and anticarcinogenic agents |
| 08/01/2000 | US6096290 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 08/01/2000 | CA2209925C 5,6-diaryl-5,6,7,8-tetrahydronaphthalenes and their analogs as estrogen agonists/antagonists |
| 08/01/2000 | CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 08/01/2000 | CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/30/2000 | CA2297225A1 O-substituted hydroxycoumaranone derivatives as antitumor and antimetastatic agents |
| 07/29/2000 | CA2290771A1 Azithromycin combination for emesis control in dogs |
| 07/28/2000 | CA2411293A1 Novel azalides and methods of making same |
| 07/27/2000 | WO2000043790A2 Compositions and methods for the diagnosis and treatment of tumor |
| 07/27/2000 | WO2000043781A2 Growth differentiation factor inhibitors and uses therefor |
| 07/27/2000 | WO2000043553A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/27/2000 | WO2000043511A1 Polypeptide |
| 07/27/2000 | WO2000043501A2 Ribozymes directed against the catalytic subunit of the human telomerase (htert) |
| 07/27/2000 | WO2000043498A2 Human liver progenitors |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043435A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/27/2000 | WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043408A2 Steroid sulfatase inhibitors and methods for making and using the same |
| 07/27/2000 | WO2000043407A1 Remedies |
| 07/27/2000 | WO2000043405A1 Bis-terpyridine-platinum(ii) complexes |
| 07/27/2000 | WO2000043404A1 Phosphinic pseudopeptides inhibitors of matrix metalloproteases |
| 07/27/2000 | WO2000043403A1 2-methyl-3-butenyl-1-pyrophosphoric acid salts and agents for treating lymphocytes |
| 07/27/2000 | WO2000043401A1 Boron steroid mimics and pharmaceutical compositions |
| 07/27/2000 | WO2000043394A1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof |
| 07/27/2000 | WO2000043393A1 Novel angiogenesis inhibitors |
| 07/27/2000 | WO2000043385A1 Heterocyclic compounds and antitumor agents containing the same as the active ingredient |
| 07/27/2000 | WO2000043378A1 New morpholinobenzamide salts |
| 07/27/2000 | WO2000043373A2 Kinase inhibitors |
| 07/27/2000 | WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/27/2000 | WO2000043366A1 Quinoline derivatives and quinazoline derivatives |
| 07/27/2000 | WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery |
| 07/27/2000 | WO2000043045A1 Method for improved radiation therapy |
| 07/27/2000 | WO2000043043A1 Ligand-peg post-coating stabilized lipoplex and polyplex for targeted gene delivery |
| 07/27/2000 | WO2000043038A1 Methods and devices for delivery of agents to breast milk ducts |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000043018A1 Medicinal compositions |
| 07/27/2000 | WO2000043016A1 DICARBA-closo-DODECABORANE DERIVATIVES |
| 07/27/2000 | WO2000043010A1 Acyl derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
| 07/27/2000 | WO2000043009A1 Pyridine compounds, use and preparation thereof |
| 07/27/2000 | WO2000043008A1 Anti-androgens and methods for treating disease |
| 07/27/2000 | WO2000043000A1 Proteasome inhibitors |
| 07/27/2000 | WO2000042989A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/27/2000 | WO2000042973A2 Homing pro-apoptotic conjugates and methods of using same |
| 07/27/2000 | WO2000042849A1 COMPLEX OF RAS-FARNESYLTRANSFERASE INHIBITOR AND SULFOBUTYLETHER-7-β-CYCLODEXTRIN OR 2-HYDROXYPROPYL-β-CYCLODEXTRIN AND METHOD |
| 07/27/2000 | WO2000042841A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 07/27/2000 | WO2000042832A2 New compounds for the treatment of cancer |
| 07/27/2000 | WO2000028010A3 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 07/27/2000 | WO2000027883A3 A method of treating tumors using fas-induced apoptosis |
| 07/27/2000 | WO2000027832A3 Thiazole derivatives as ppar gamma ligands |
| 07/27/2000 | WO2000023592A3 Minimal promoters and uses thereof |
| 07/27/2000 | WO2000023433A8 Substituted benzopyran analogs for the treatment of inflammation |
| 07/27/2000 | WO2000023096A3 Combination therapy with vip antagonist |
| 07/27/2000 | WO2000018915A3 Membrane-associated organizational proteins |
| 07/27/2000 | WO2000017328A3 Fibrils |
| 07/27/2000 | WO2000012683A9 Stem cells bearing an fgf receptor on the cell surface |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | WO2000008202A9 3-methylidenyl-2-indolinone modulators of protein kinase |
| 07/27/2000 | DE10003356A1 Novel ribozymes targeted against the catalytic subunit of the human telomerase enzyme reverse transcriptase are useful for treating tumors |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2361168A1 Steroid sulfatase inhibitors and methods for making and using the same |
| 07/27/2000 | CA2361123A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 07/27/2000 | CA2361122A1 Methods and devices for delivery of agents to breast milk ducts |
| 07/27/2000 | CA2361064A1 Boron steroid mimics and pharmaceutical compositions |